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Membrane phosphoinositides control organization and
dynamics of the actin cytoskeleton by regulating the activities of
several key actin-binding proteins. Twinfilin is an evolutionarily
conserved protein that contributes to cytoskeletal dynamics by
interacting with actin monomers, filaments, and the heterodi-
meric capping protein. Twinfilin also binds phosphoinositides,
which inhibit its interactions with actin, but the underlying
mechanism has remained unknown. Here, we show that the
high-affinity binding site of twinfilin for phosphoinositides is
located at the C-terminal tail region, whereas the two actin-de-
polymerizing factor (ADF)/cofilin–likeADFhomology domains
of twinfilin bind phosphoinositides only with low affinity.
Mutagenesis and biochemical experiments combined with
atomisticmolecular dynamics simulations reveal that theC-ter-
minal tail of twinfilin interacts with membranes through amul-
tivalent electrostatic interactionwith a preference toward phos-
phatidylinositol 3,5-bisphosphate (PI(3,5)P2), PI(4,5)P2, and
PI(3,4,5)P3. This initial interaction places the actin-binding
ADF homology domains of twinfilin in close proximity to the
membrane and subsequently promotes their association with
the membrane, thus leading to inhibition of the actin interac-
tions. In support of this model, a twinfilin mutant lacking the
C-terminal tail inhibits actin filament assembly in a phosphoi-
nositide-insensitive manner. Our mutagenesis data also reveal
that the phosphoinositide- and capping protein–binding sites
overlap in the C-terminal tail of twinfilin, suggesting that phos-
phoinositide binding additionally inhibits the interactions of
twinfilin with the heterodimeric capping protein. The results
demonstrate that the conserved C-terminal tail of twinfilin is a
multifunctional binding motif, which is crucial for interaction
with the heterodimeric capping protein and for tethering twin-
filin to phosphoinositide-rich membranes.
The dynamic interplay between the actin cytoskeleton and
plasmamembrane is critical for several cellular processes, such
as migration, morphogenesis, endocytosis, and phagocytosis.
Coordinated polymerization of actin filaments provides a force
for generation of membrane invaginations in endocytic pro-
cesses (1, 2). In migrating cells, polymerization of actin fila-
ments against the plasmamembrane at the leading edge pushes
the membrane forward to generate plasma membrane protru-
sions, such as lamellipodia and filopodia (3–6).
Although actin polymerization controls the geometry of
cellular membranes, membrane phospholipids, especially
PI(4,5)P2,2 reciprocally regulate the organization and dynamics
of the actin cytoskeleton. Typically, an increase in the plasma
membrane PI(4,5)P2 density leads to actin filament assembly
beneath the membrane, whereas a decrease in PI(4,5)P2 con-
centration results in diminished actin filament assembly
(7–10). Phosphoinositides regulate actin filament assembly and
disassembly by directly interacting with several actin-binding
proteins (11). The activities and the plasma membrane target-
ing of actin-binding proteins promoting actin filament assem-
bly in cells, such as N-WASP, Dia1, and Dia2, are often posi-
tively regulated by phosphoinositides. In contrast, proteins
promoting actin filament disassembly (e.g. ADF/cofilins and
gelsolin) and preventing actin filament assembly (e.g. heterodi-
meric capping protein) are inhibited by interactions with phos-
phoinositides (12–17). Binding sites for phosphoinositides and
actin overlap on surfaces of ADF/cofilins and heterodimeric
capping protein, providing a molecular explanation as to why
these proteins are inhibited through interactions with PI(4,5)P2
(18–21).
Twinfilin is an evolutionarily conserved actin-binding pro-
tein that regulates cytoskeletal dynamics in organisms from
yeasts to mammals (22). Lower eukaryotes, such as yeasts and
Drosophila, have one twinfilin gene (23, 24), whereas mammals
have two genes, namely twinfilin-1 and twinfilin-2 (25). All
twinfilins consist of two actin-depolymerizing factor homology
(ADF-H) domains separated by a short linker and followed by a
short C-terminal tail region. Twinfilins are involved in several
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cell migration (26, 27), endocytosis (28, 29), epithelial-to-mesen-
chymal transition (30), morphology of inner ear stereocilia (31),
axonal growth of neurons (27), and platelet activation (32).More-
over, human twinfilin-1 has been shown to facilitate resistance to
chemotherapy agents in breast cancer and lymphoma (26, 30).
Twinfilins contribute to cytoskeletal dynamics through a
complexmechanismthat involves interactionswithactinmono-
mers, actin filaments, and heterodimeric capping protein. Both
yeast and mammalian twinfilins bind ADP-actin monomers
with high affinity and inhibit their nucleotide exchange and
assembly into filament ends (23, 33, 34). Mammalian twinfilins
can additionally cap actin filament barbed ends with a prefer-
ence toward ADP-actin–containing filament ends (29, 35, 36).
Moreover, the budding yeast twinfilin, together with the
cyclase-associated protein, can accelerate actin filament de-
polymerization from the barbed and pointed ends (37). The
high-affinity ADP-actin monomer–binding site is located in
the C-terminal ADF-H domain of twinfilin, whereas the pres-
ence of both actin-binding ADF-H domains is required for
twinfilin’s filament barbed end capping and filament depoly-
merization activities (34, 35, 37). In addition to actin, yeast and
mammalian twinfilins interact with the heterodimeric capping
protein.Mutagenesis studies demonstrated that theC-terminal
tail of twinfilin is critical for interaction with capping protein
and for proper subcellular localization of twinfilin in cells (38,
39). However, this interaction does not appear to affect the
actin-related activities of twinfilin or capping protein, at least
not in vitro, and thus the biological role of the twinfilin-capping
protein interaction has remained largely unknown.
Budding yeast twinfilin and mammalian twinfilin-1 and
twinfilin-2 also interact with phosphoinositides. Interaction
withPI(4,5)P2 inhibits theabilityof twinfilin tobindactinmono-
mers and decelerate actin filament assembly (25, 38). Hence,
similarly to structurally related ADF/cofilins, the actin interac-
tions of twinfilin are inhibited by phosphoinositides (38, 39).
However, themechanism of twinfilin-PI(4,5)P2 interaction and
the location of the phosphoinositide-binding site(s) in twinfilin
are unknown. Also, the cellular roles and possible effects of the
phosphoinositide interaction on other biochemical functions
of twinfilin remain to be elucidated.
Here, we utilized a combination of mutagenesis and bio-
chemical experiments together with atomistic molecular
dynamics simulations to expose how mouse twinfilin-1 (here-
after twinfilin) interacts with phosphoinositide-rich mem-
branes. Our results revealed that twinfilin is initially tethered to
the phosphoinositide-rich membrane through its conserved
C-terminal tail. Further on,we found that this interaction forces
the actin-bindingADF-Hdomains in close proximity to themem-
brane and subsequently leads to inactivation of actin binding by
twinfilin. Thus, twinfilin utilizes a novel two-step mechanism for
interactions with phosphoinositide-richmembranes.
Results
Twinfilin binds phosphoinositide-richmembranes via
electrostatic interactions
Previous studies on twinfilin-phosphoinositide interactions
were performed with the non-quantitative native gel electro-
phoresis approach using micelles comprising only phosphoi-
nositides (25, 38). Here, we applied vesicle cosedimentation,
coflotation, and fluorometric assays with vesicles based on
more physiological lipid compositions to study the mechanism
bywhich twinfilin interactswith lipids. Cosedimentation assays
performed with vesicles containing 5% phosphoinositides
(PI(3)P, PI(4)P, PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, or PI(3,4,5)P3)
mixed with other abundant lipid species found at the inner
leaflet of the plasma membrane (see “Experimental proce-
dures”) revealed that twinfilin has highest affinity toward vesi-
cles containing PI(3,5)P2, PI(4,5)P2, and PI(3,4,5)P3 (Fig. 1A and
Fig. S1). Twinfilin therefore displays the strongest binding to
lipids with a high net negative charge andmay additionally pre-
fer PIPs having a phosphate group in the C-5 position of the
inositol ring. We also tested whether the twinfilin-lipid inter-
action is sensitive to phosphoinositide density by carrying out
a vesicle cosedimentation assay with vesicles of different
PI(4,5)P2 densities (0–20%). These experiments revealed a rel-
atively linear correlation between the amount of cosedimenting
twinfilin and the PI(4,5)P2 density of the vesicles (Fig. 1B).
Thus, compared with the sharp phosphoinositide-density
thresholds reported for N-WASP and cofilin binding to mem-
branes (19, 40), twinfilin does not respond in a switchlike man-
ner to a small increase in phosphoinositide density, although it
nevertheless preferentially binds vesicles with a high PI(4,5)P2
density.
To examine whether twinfilin interacts with membranes via
electrostatic interactions, we performed vesicle cosedimenta-
tion assays at different sodium chloride concentrations (0, 100,
250, and 500 mM). The results revealed a clear negative corre-
lation between twinfilin-vesicle interactions and an increasing
salt concentration, suggesting that twinfilin associates with
membranes through electrostatic interactions (Fig. 1C). Next,
we utilized a 1,6-diphenyl-1,3,5-hexatriene (DPH) anisotropy
assay to examinewhether twinfilin inserts into a lipid bilayer. In
this assay, the insertion of a protein motif into the bilayer
changes rotational diffusion and hence the anisotropy of the
hydrophobic DPH probe (41). Whereas the I-BAR domain of
missing-in-metastasis (MIM) protein, containing amembrane-
inserting amphipathic helix (42), resulted in an increase in the
DPH anisotropy, twinfilin did not induce a detectable effect on
DPH anisotropy even at high protein concentrations (Fig. 1D).
Together, these data show that twinfilin interacts with nega-
tively charged phosphoinositides via electrostatic interactions
and does not penetrate the hydrophobic acyl chain region of the
lipid bilayer.
The positively charged C-terminal tail facilitates interaction of
twinfilin with phosphoinositides
Because PI(4,5)P2 inhibits the actin-binding function of
twinfilin (25, 38), we hypothesized that the binding site for
PI(4,5)P2 overlaps with the actin-binding sites in the ADF-H
domains (43, 44). In support of this hypothesis, ADF/cofilins,
which are entirely composed of a structurally similar ADF-H
domain, bind PI(4,5)P2 (12, 19, 45) although with relatively low
affinity (21). We thus expressed and purified different domains
of twinfilin (Fig. 2A) and applied a vesicle cosedimentation
assay to study their interactionswith lipid vesicles. Surprisingly,
Mechanism of twinfilin-PI(4,5)P2 interaction
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the isolated N-terminal ADF-H domain (TWF1(1–174)) did
not exhibit detectable affinity toward lipids, and the C-terminal
ADF-H domain (TWF1(169–316)) bound PI(4,5)P2-rich vesi-
cles only with very low affinity. Moreover, a construct compris-
ing the two ADF-H domains, thus lacking only the C-terminal
tail (TWF1(1–316)), bound phosphoinositide-rich vesicles
with low affinity. In contrast, full-length twinfilin (TWF1(1–
350)) and the protein containing the C-terminal ADF-H
domain and the C-terminal tail (TWF1(169–350)) bound lipid
vesicleswith a relatively high affinitywith apparent dissociation
constants of 247 and 414 M, respectively (Fig. 2B). We there-
fore reasoned that the C-terminal tail region of twinfilin is
essential for high-affinity interactions with lipids. This result
was confirmed by a coflotation assay where the twinfilin con-
struct containing the C-terminal ADF-H domain and the tail
region (TWF1(169–350)) was enriched with lipids in fraction
2, whereas the isolated ADF-H domain without the tail
(TWF1(169–316)) failed to accumulate in the lipid-containing
fraction (Fig. 2C).
We also tested whether the isolated C-terminal tail of twin-
filin could interact with lipids. For this purpose, we prepared a
construct in which the C-terminal tail of twinfilin is fused to
glutathione S-transferase (GST). Importantly, in a cosedimen-
tation assay, this fusion protein displayed much stronger bind-
ing toward phosphoinositide-rich vesicles compared with GST
alone, which also exhibited some interaction with lipids (Fig.
S2A). Moreover, in a coflotation assay, the GST-twinfilin tail
fusion protein was enriched with lipids in fraction 2, whereas
GST alone was mainly enriched in non-lipid–containing frac-
tions 3 and 4 (Fig. S2B). The isolated C-terminal tail of twinfilin
hence binds phosphoinositide-rich membranes with high
affinity.
The C-terminal tail of twinfilin contains several positively
charged residues and one aromatic residue (Phe-323), which
are likely to contribute to phosphoinositide binding. Many of
these are conserved in evolution from yeast and Drosophila to
mammals (Fig. 3A). To map the phosphoinositide-binding site
in the twinfilin tail, we performed vesicle cosedimentation
assays with truncated proteins (Fig. 3B). As shown above, a
protein lacking the entire tail region (TWF1(1–316)) did not
interact with vesicles. Addition of nine residues (TWF1(1–
325)), including four positively charged residues and one
aromatic residue, did not detectably increase the binding.
However, including five additional residues (TWF1(1–330))
increased lipid binding significantly, and the construct lacking
the sevenC-terminal residues of the tail (TWF1(1–343)) bound
phosphoinositide-rich vesicles with affinity similar to that of
the full-length protein (Fig. 3B).
To further map the PI(4,5)P2-binding site, we generated
three mutant twinfilins in which clusters of positively charged
residues of the tail were replaced by alanines (TWF1
(H317A,H319A,K320A), TWF1(K325A,K327A), and TWF1
(K332A,K333A,R335A,R336A)) and a mutant twinfilin in
which the conserved phenylalanine was replaced by alanine
(TWF1(F323A)) (Fig. 3A). All mutant proteins displayed
reduced binding to phosphoinositide-rich vesicles in a cosedi-
Figure 1. Twinfilin-1 binds lipids via electrostatic interactions. A, a vesicle cosedimentation assay. Lipid composition of vesicles was POPC:POPE:POPS:PIP 55:20:
20:5. In the “noPIP” samples, theamountofPOPCwas60%.The final proteinand lipid concentrationswere2and500M, respectively. Results are shownas individual
data points and as the mean from four experiments. Error bars represent standard deviations. B, a vesicle cosedimentation assay with increasing PI(4,5)P2 density.
Vesicle compositionwas POPC:POPE:POPS 60:20:20, and PI(4,5)P2 concentrationwas 0, 2, 4, 6, 8, 10, or 20%. The concentration of POPCwas decreased correspond-
ingly. The finalproteinand lipidconcentrationswere2and250M, respectively.C, a vesicle cosedimentationassaywith increasingNaCl concentration. Theassaywas
done in 20mMHEPES, pH7.4, and varying concentrations of NaCl (0, 100, 250, or 500mM). The final protein and lipid concentrationswere 2 and500M, respectively.
Resultsareshownas individualdatapointsandasthemeanof fourexperiments.Errorbars representstandarddeviations.D,DPHanisotropyof40Mvesicleswith lipid
composition of POPC:POPS:POPE:PI(4,5)P2:DPH 50:20:20:10:1/500with increasing twinfilin-1 orMIM I-BAR concentrations.
Mechanism of twinfilin-PI(4,5)P2 interaction
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mentation assay (Fig. 3C). However, the phenylalanine-to-ala-
nine mutant (TWF1(F323A)) displayed a less pronounced
defect in lipid binding compared with the charge-neutralized
mutants (Fig. 3C). Together, these results revealed that the
clusters of positively charged residues in the C-terminal tail
comprise the high-affinity phosphoinositide-binding site of
twinfilin. In contrast, the ADF-H domains of twinfilin bind lip-
ids only with low affinity.
Molecularmechanism underlying the binding of twinfilin to
phosphoinositide-richmembranes
To reveal the mechanism by which twinfilin binds to
PI(4,5)P2-rich membranes, we utilized atomistic molecular
dynamics (MD) simulations. Experimental results discussed
above suggest that theC-terminal tail plays an important role in
this process. Crystal and solution structures of the N-terminal
and C-terminal ADF-H domains have been determined (35, 43,
44, 46), but the structure of the 34-residue-long C-terminal tail
region (residues 317–350) has remained unknown. To explore
the secondary structure of the twinfilin tail, we first utilized
unbiased MD simulations of the C-terminal tail region
detached from the rest of the protein. The MD simulations
indicated the C-terminal tail region to be mainly unfolded with
transient structures consistent with -helical and partially
-turn conformations. Then we constructed a more complete
description for a twinfilin fragment containing the C-terminal
ADF-H domain and the 34-residue C-terminal tail, whose
structure was consistent with the above described simulations.
Details of these simulations are discussed in the supporting
information.
To elucidate the structural mechanism of the twinfilin inter-
action with a PI(4,5)P2-rich membrane, we performed a series
of simulations with different twinfilin fragments using asym-
metric membranes (see “Experimental procedures”). We first
compared the membrane binding of the C-terminal ADF-H
domainwith the tail in an-helical conformation (system 5; see
Table S1) and theADF-Hdomain alonewithout the tail (system
10). The ADF-H domain linked to the -helical tail interacted
more strongly with lipid bilayer compared with the ADF-H
domain without the tail (Fig. S4, Movie S3, and Movie S4). We
next studied the interaction of the -helical tail attached to the
ADF-H domain (system 5) more closely. In four independent
simulations, this protein bound to the PI(4,5)P2-rich leaflet
with the C-terminal tail leading the binding process (Fig. 4A
and Movie S3). This could be visualized by following the dis-
tance between any lipid in a membrane and residues Arg-267
and Arg-269 in the actin-binding region of the ADF-H domain
and residues Lys-323 and Lys-325 in the C-terminal tail region
(Fig. 4B). In all four simulations, the residues in the tail region
bound lipids first followed by the residues in the ADF-H
domain (Fig. 4C). The C-terminal tail remained on the mem-
brane surface instead of being inserted into the membrane.
Interestingly, of the key residues in the tail that interacted with
PI(4,5)P2 or other lipids (Lys-320, Ser-322, Lys-325, Lys-327,
Gly-328, Gly-331, Lys-332, Arg-333, Arg-336, Arg-337, and
Arg-340), eight are charged (lysines and arginines), and of the
residues in the ADF-H domain that interacted with lipids (Ser-
265, Arg-267, Arg-269, Arg-285, and Asp-298), four of the five
are also charged (arginines and aspartic acid) (Fig. S5, left
panel). This strongly suggests that the binding process is driven
by electrostatics. We note that two of six repeats of system 5
hovered early on onto a negatively charged PI(4,5)P2-free leaflet
due to sensitivity to initial conditions. These simulation repeats
were interrupted because it would require much larger times-
cales to reproduce the binding process on the other leaflet.
To test the role of electrostatic interactions between the
membrane and the protein as the driving force for membrane
binding,weneutralized all the positively charged residues in the
C-terminal tail of the protein starting from the -helical con-
formation (system 11). In all six repeats of themembrane-bind-
ing simulations (Fig. S5, right panel), we observed unstable and
Figure2.The tail regionof twinfilin is crucial for its interactionswith lipid
vesicles. A, the domain organization of mouse twinfilin-1 and its truncated
versions used in this study. The protein is composed of two actin-binding
ADF-H domains, a linker region (L), and a C-terminal tail (T). B, a cosedimenta-
tion assay performed at different lipid concentrations. The final protein con-
centration was 2 M, and the lipid concentration varied from 0 to 1000 M.
The lipid compositionwas POPC:POPE:POPS:PI(4,5)P2 50:20:20:10 in all exper-
iments. Data were fitted to the equation y Vmax [x]/(KD [x]). Results are
shown as individual data points and as the mean of four experiments. Error
bars represent standard deviations. C, a vesicle coflotation assay with final
protein and lipid concentrations of 1 M and 1 mM, respectively. The lipid
composition was as in B.
Mechanism of twinfilin-PI(4,5)P2 interaction
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unspecific association with the negatively charged leaflet of the
membrane, although the secondary structure of the C-terminal
tail remained helical throughout simulations. The unspecific
adsorption is evident from the contact frequency plots shown in
Fig. S5, which not only shows the divergence in the set of resi-
dues that contact the membrane but also the diminishedmem-
brane-interacting role of the C-terminal tail in all six repeats
(Fig. S5, right panel). These simulations further support the
importance of the charged residues in the C-terminal tail for
proper initial association with the membrane and convergence
to a well-defined membrane-binding mode.
To confirm that the -helical conformation is important for
membrane binding of the C-terminal tail, we constructed two
additional twinfilin structures: the C-terminal ADF-H domain
combined with the tail either in a random coil conformation
(system 6) or in a-sheet conformation (system 7). In five inde-
pendent simulations, we observed only weak binding coupled
to short residence times spent on the membrane or no binding
at all as shown by the atom number densities estimated from
the simulations for each tail conformation (Movie S5,Movie S6,
and Fig. S6). The overlap of the densities clearly shows the con-
vergence of the membrane-binding interactions of the C-ter-
minal tail andC-terminal ADF-Hdomain regions of twinfilin in
four of six simulations when the tail is in an -helical confor-
mation (Fig. S6, upper panel). However, other conformations of
the tail fail to bind the membrane, interact unspecifically with
it, or associate with the PI(4,5)P2-free leaflet (Fig. S6, middle
and lower panels). The weaker lipid binding of the -sheet con-
formation compared with that of the -helical conformation is
supported by the presence of a more pronounced positive elec-
trostatic potential in the tail region when it is in the -helical
conformation (Fig. S3C) compared with the -sheet conforma-
tion (Fig. S3F). We also performed simulations of the isolated
C-terminal tail in the -helical conformation (system 9). These
simulations revealed that the-helical tail binds themembrane
also in the absence of the ADF-H domain (Movie S7). All
charged amino acid residues in the tail interact strongly with
phosphoinositides, again highlighting the importance of elec-
trostatic interactions in the membrane-binding process.
Finally, we performed a Define Secondary Structure of Pro-
tein (DSSP) analysis for the initial simulation structures and the
last 50 ns of simulations of the C-terminal tail to reveal possible
conformation changes (Fig. S7). The secondary structure of the
protein remained almost entirely unchanged within the times-
cales of the simulations in all repeats regardless of the initial
secondary structure of theC terminus and interactionswith the
membrane. In the case of the random coil simulations, how-
ever, the initially present short stretch of the helix at the very C
terminus appeared to be less stable, adopting some structure or
showing signs of becoming unstructured (Fig. S7).
Collectively, our atomistic MD simulations provided com-
pelling evidence that twinfilin binds to phosphoinositide-rich
membranes by its C-terminal tail, which does not penetrate the
bilayer but instead lies along the membrane plane, interacting
simultaneously with several lipid headgroups (Fig. S4). The
driving force for membrane binding is the electrostatic interac-
tions. The binding is the strongest when the tail has a transient
-helical structure that renders strong electrostatic interac-
tions between the charged residues and PI(4,5)P2 possible.
Moreover, independent simulations of this structure provided
evidence for a two-step mechanism where the strong associa-
tion of the C-terminal tail with lipids places the ADF-H domain
in close proximity to the membrane. The ADF-H domain sub-
sequently interacts with phosphoinositides through charged
residues that are also critical for its actin binding, hence provid-
Figure 3. Clusters of positively charged residues in the tail of twinfilin facilitate its lipid interactions.A, a sequence alignment of tail regions frommouse
andhuman twinfilin-1 aswell as fruit fly andbudding yeast twinfilins. Clusters of positively charged residuesmutated to alanines are highlightedwith *,, and
. The conserved phenylalanine mutated for biochemical experiments is highlighted with #. B, a vesicle cosedimentation assay preformed on full-length
twinfilin-1 and C-terminally truncated proteins. C, vesicle cosedimentation assays carried out on wild-type twinfilin-1 and mutant proteins. The final protein
and lipid concentrationswere2and500M, respectively, and the lipid compositionwasPOPC:POPS:POPE:PI(4,5)P2 50:20:20:10. Results are shownas individual
data points and as themean of four experiments. Error bars represent standard deviations. Statistical significance was calculatedwith Student’s t test. ***, p
0.001; *, p 0.05. n.d., not detectable.
Mechanism of twinfilin-PI(4,5)P2 interaction
4822 J. Biol. Chem. (2018) 293(13) 4818–4829
 at U
niversity of H
elsinki on N
ovem
ber 19, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ing a structural explanation for the PI(4,5)P2-induced inactiva-
tion of twinfilin-actin interactions.
The C-terminal tail is crucial for regulation of twinfilin by
phosphoinositides
To test the model where the C-terminal tail tethers twinfilin
to the phosphoinositide-rich membrane, we applied an actin
filament sedimentation assay. Here, we compared the abilities
of full-length twinfilin (TWF1(1–350)) and a protein lacking
the C-terminal tail (TWF1(1–316)) to inhibit actin filament
assembly (i.e. to shift actin from the pellet (F-actin) to the
supernatant (G-actin) fraction) in the absence and presence of
PI(4,5)P2-rich vesicles. Both full-length twinfilin and the pro-
tein lacking the C-terminal tail efficiently inhibited actin fila-
ment assembly in the absence of lipids (Fig. 5, A and B). How-
ever, the inhibition effect of full-length twinfilin comparedwith
mutant TWF1(1–316) was slightly stronger due to its higher
affinity toward filament barbed ends (35).When these proteins
were first incubated with PI(4,5)P2-rich vesicles, the ability of
full-length twinfilin to inhibit actin polymerizationwas severely
diminished, although lipids could not completely inhibit full-
length twinfilin possibly due to saturation of exposed PI(4,5)P2
lipids at high protein concentrations (Fig. 5A). In contrast, the
ability of the protein lacking the C-terminal tail to inhibit actin
filament assembly was only mildly affected by PI(4,5)P2-rich
vesicles (Fig. 5B). Together with the mutagenesis andMD sim-
ulations presented above, these biochemical data show that the
C-terminal tail is crucial for anchoring twinfilin to the mem-
brane and subsequently inhibiting the actin-binding activity of
the nearby ADF-H domain by forcing it into close contact with
the phosphoinositide-rich membrane.
The binding sites for phosphoinositides and capping protein
overlap in the C-terminal tail of twinfilin
Twinfilins also interact with the heterodimeric capping pro-
tein, and the C-terminal tail is important in this interaction
Figure 4. Atomistic simulations to explore twinfilin-membrane interaction.A, snapshots froma simulationwith the C-terminal ADF-Hdomain and the tail
(TWF1(169–350)) together with a phosphoinositide-rich membrane (system 5 in Table S1). The lipid composition in the upper membrane leaflet was POPC:
POPS:POPE 60:20:20, and that in the lower leaflet was POPC:POPS:POPE:PI(4,5)P2 50:20:20:10. The tail of twinfilin is shown in yellow, and PI(4,5)P2 in the
membrane is depicted in light red. B, the final conformation of TWF1(169–350) on amembrane. PI(4,5)P2 in themembrane is depicted in light red. Two residues
at the actin-binding regionof theADF-Hdomain (Arg-267 andArg-269) and two residues in the twinfilin tail (Lys-325 and Lys-327) are highlighted.C,minimum
distance between lipids of the PI(4,5)P2-rich leaflet and residues Arg-267, Arg-269, Lys-325, and Lys-327 during four independent simulations. Residues in the
C-terminal tail (Lys-325 and Lys-327) equilibrated much faster onto the plasma membrane compared with the residues in the ADF-H domain (Arg-267 and
Arg-269).
Mechanism of twinfilin-PI(4,5)P2 interaction
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(39). To examine whether the phosphoinositide- and capping
protein–binding sites overlap the C-terminal tail of twinfilin,
we utilized themicroscale thermophoresis (MST)method (47–
49) to measure the affinities of wildtype and mutant twinfilins
to EGFP-tagged capping protein. Consistent with an earlier
study (39), twinfilin lacking the C-terminal tail (TWF1(169–
316)) exhibited only low affinity toward capping protein (Fig.
6D), whereas the full-length twinfilin (TWF1(1–350)) and the
protein lacking the N-terminal ADF-H domain (TWF1(169–
350)) bound capping protein with submicromolar affinities
(Fig. 6,A andB). Importantly, also the isolated tail fused toGST
(TWF1(316–350)) bound capping protein, although the affin-
ity was 5-fold lower compared with that of the full-length
protein (Fig. 6C). Please note that the decrease in the thermo-
phoretic signal at high TWF1(169–316) concentrations may
also result from nonspecific interactions of this protein and
EGFP at high concentrations, leading to quenching of EGFP
fluorescence.
Next, wemeasured the binding affinities of the mutant twin-
filins that displayed defects in PI(4,5)P2 interactions with the
EGFP-tagged capping protein. Three mutants, TWF1(F323A),
TWF1(K325A,K327A), and TWF1(K332A,K333A,R335A,
R336A), exhibited only very low (20-fold decreased) affinity
to capping protein (Fig. 6, F–H), whereas one mutant,
TWF1(H317A,H319A,K320A), displayed about 5-fold lower
affinity to capping protein compared with the wildtype protein
(Fig. 6E). Together, these results demonstrate that the isolated
C-terminal tail of twinfilin is sufficient for interactions with
capping protein and that the binding sites for PI(4,5)P2-rich
membranes and capping protein overlap in the C-terminal tail
of twinfilin.
Discussion
Twinfilin is an evolutionarily conserved actin-binding pro-
tein, whose activity is inhibited by phosphoinositides. In this
work, we utilized a combination of mutagenesis and biochem-
ical studies aswell as atomisticmolecular dynamics simulations
to elucidate themechanismunderlying the interaction between
twinfilin and phosphoinositide-rich membranes. Strikingly, we
found that the high-affinity lipid-binding site is located at the
C-terminal tail of twinfilin and that the actin-binding ADF-H
domains bind phosphoinositide-richmembranes only with low
affinity. We also demonstrated that the binding sites for cap-
ping protein and phosphoinositides overlap in the C-terminal
tail of twinfilin. The atomistic simulation data provided evi-
dence that twinfilin is initially tethered to the membrane
through its C-terminal tail, which has a transient -helical
structure, and that this interaction subsequently forces the
ADF-H domains to associate with themembrane, hence result-
ing in inhibition of their actin-binding activities. This paradigm
is also supported by biochemical data demonstrating that a
twinfilin mutant lacking the C-terminal tail regulates actin
dynamics in a phosphoinositide-insensitive manner.
Twinfilin is composed of two ADF/cofilin–like ADF-H
domains. Our cosedimentation and DPH anisotropy experi-
ments as well as atomistic simulations demonstrated that, sim-
ilarly toADF/cofilins (19, 21), twinfilin interactswith negatively
charged phospholipids through electrostatic interactions with-
out penetrating the hydrophobic acyl chain region of the
bilayer. However, the isolated N-terminal ADF-H domain of
twinfilin does not bind lipids with detectable affinity, and the
C-terminal ADF-H domain displays only relatively modest
binding to lipids in vitro. These results are consistent with a
recent study demonstrating that ADF/cofilins display only
transient, low-affinity interactions with phosphoinositide-rich
membranes (21). Importantly, our experiments revealed that
full-length twinfilin bindsmembranesmore strongly compared
with ADF/cofilins and that the C-terminal tail of twinfilin is
critical for this high-affinity lipid binding. Thus, the ADF-H
domains appear to interact with membranes only with low
affinity and seem to require additional protein motifs (e.g. the
C-terminal tail in the case of twinfilin) for strong association
with membranes.
Our data revealed that the isolatedC-terminal tail of twinfilin
is sufficient for interactions with both phosphoinositides and
capping protein.Moreover, ourmutagenesis experiments dem-
onstrated that the positively charged residues (Lys-325, Lys-
327, Lys-332, Lys-333, Arg-335, and Arg-336) and the aromatic
residue (Phe-323) at the central region of the tail are critical for
interactions with both phosphoinositides and capping protein.
Residues near the beginning of the tail (His-317, Lys-319, and
Lys-320) also contribute to these interactions but are not as
crucial as the residues in the central region. The overlapping
Figure 5. The C-terminal tail is critical for regulation of twinfilin by PI(4,5)P2.An actin filament cosedimentation assay was performed in the absence and
presence of phosphoinositide-rich vesicles for the full-length twinfilin (TWF1(1–350)) (A) and for a protein where the C-terminal tail was deleted (B). Actin and
lipid concentrations were 3 M and 1 mM, respectively, and the lipid composition was POPC:POPS:POPE:PI(4,5)P2 40:20:20:20. Each data point is the mean of
four independent experiments. Error bars represent standard deviations. Please note that the full-length and the C-terminally deleted twinfilins efficiently
increased the amount of monomeric actin in the absence of lipids. However, only the full-length twinfilin could be efficiently inhibited by addition of
phosphoinositide-rich vesicles. The sigmoidal behavior in TWF1(1–350)  1 mM lipid samples in A most likely result from saturation of PI(4,5)P2 with high
concentrations of TWF1.
Mechanism of twinfilin-PI(4,5)P2 interaction
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binding sites suggest that, in addition to actin binding (25, 38),
phosphoinositides inhibit interactions between twinfilin and
capping protein. However, because both twinfilin and capping
protein bind lipids with high affinity (20, 50), it is technically
difficult to provide direct experimental evidence (e.g. by using
pulldown, vesicle cosedimentation, or vesicle coflotation
assays) that twinfilin does not bind capping protein in the pres-
ence of phosphoinositide-rich membranes.
Our atomisticMD simulations and biochemical data provide
evidence for a novel two-step mechanism for twinfilin inhibi-
tion by phosphoinositides (Fig. 7). Whereas the other actin-
binding proteins examined so far, including ADF/cofilins and
capping protein (19, 21, 50), directly associate withmembranes
through their actin-binding sites, twinfilin does not utilize its
actin-binding site for initial interactions with the membrane.
The high-affinity actin-binding site is located in the C-terminal
ADF-H domain of twinfilin (34). Our simulation data suggest
that the adjacentC-terminal tail is a relatively flexible, extended
structure with some -helical content. The tail also contains
the high-affinity lipid-binding site, and when encountering a
phosphoinositide-rich membrane it can tether the protein on
the surface of the lipid bilayer. Interestingly, a cluster of posi-
tively charged arginines in the tail has a spacing of (n, n3) or
(n,n 4), creating a surface of positive charge on one side of the
helical tail that interacts with lipids (Fig. S8). This further sup-
ports the proposed partially helical structure as the lipid-bind-
ing interface. Because the C-terminal ADF-H domain binds
actin and phosphoinositides through an overlapping interface,
Figure 6. Microscale thermophoresis (MST) assay demonstrating that the C-terminal tail of twinfilin-1 interacts with capping protein. A–H, the
normalized changes in thermophoretic signalswith50nMEGFP-cappingprotein in thepresenceofdifferent concentrationsof full-length twinfilin and twinfilin
fragments (A–D) or proteins with point mutations in the C-terminal tail (E–H). Each curve represents the fitting of an individual experiment. KD represents a
mean of three to four independent experiments, and a standard deviation is shown.
Mechanism of twinfilin-PI(4,5)P2 interaction
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tethering this domain to themembrane through theC-terminal
tail results in its association with phosphoinositides and conse-
quent inhibition of the actin-binding activity (see Movie S3).
The membrane-bound, inactive twinfilin molecule can then be
released from the membrane either spontaneously (assuming
that its off-rate from themembrane is rather rapid) or following
PI(4,5)P2 hydrolysis.
In cells, twinfilin localizes to regions of high actin turnover,
such as lamellipodia, filopodia, cell–cell junctions, and sites of
endocytosis (25, 29). Interestingly, these cellular regions are
also enriched in specific phosphoinositides and are under
dynamic regulation of several phosphoinositide kinases and
phosphatases (7, 51–53). Moreover, epidermal growth factor
(EGF)-induced hydrolysis of PI(4,5)P2 has been suggested to
release cofilin from the plasma membrane to activate the pro-
tein in carcinoma cells (54). We thus hypothesize that phos-
phoinositides can control the subcellular localization of twinfi-
lin and regulate its activities in cells during lamellipodial
protrusions and retractions. Because twinfilin promotes actin
filament disassembly and inhibits actin filament assembly (23,
25, 29, 34, 37), a local decrease in the plasma membrane
PI(4,5)P2 density may lead to a displacement of twinfilin
from the membrane and subsequently unleash it to promote
actin filament disassembly. To study the in vivo role of twin-
filin-phosphoinositide interaction in the future, it will be
important to identify twinfilin mutants that specifically
inhibit its lipid-binding activity. Because twinfilin is linked
to several diseases, such as lymphoma (26) and breast cancer
(30) progression and chemoresistance, it will also be impor-
tant to elucidate the possible role of twinfilin-phosphoi-
nositide interactions, as well as other regulatory mecha-
nisms of twinfilin, in these disorders.
Experimental procedures
Plasmids
Mouse twinfilin-1 cDNA was amplified with Phusion
polymerase (Thermo Fisher) and cloned to pGAT2 bacterial
expression vector using NcoI and HindIII restriction (Thermo
Fisher). Point mutations were introduced to twinfilin-1 using
the quick-change mutagenesis method with the KAPA HiFi
HotStart ReadyMix PCR kit (Kapa Biosystems). Truncated
cDNAs were generated by introducing a premature stop codon
to twinfilin-1 gene with the KAPA HiFi HotStart ReadyMix
PCR kit. A tail fragment of twinfilin-1 was cloned to the pGEX-
6P-1 bacterial expression vector with SalI and EcoRI restriction
enzymes (Thermo Fisher). Mouse capping protein subunits 1
and 2 were cloned to pRSFDuet1 bacterial expression vector
containing N-terminal EGFP protein with EcoRI/HindIII and
NdeI/XhoI, respectively.
Proteins
All proteins were expressed in either Escherichia coli BL21
(DE3) cells in Luria broth with isopropyl 1-thio--D-galactopy-
ranoside induction or in E. coli BL21 (DE3) pLysS cells in auto-
induction Luria broth (Formedium). Cells were lysed with an
EmulsiFlex-C3 homogenizer (Avestin). GST-tagged twinfilins
were immobilized with glutathione-agarose beads (Thermo
Fisher and Sigma-Aldrich) and washed several times with 50
mM Tris-HCl, pH 7.5, 150 mM NaCl, 2.5 mM CaCl2 buffer, and
GST tag was cleaved with 10 units/ml thrombin (Sigma-Al-
drich). Proteins were further purified with a Superdex-75 gel
filtration column (GE Healthcare) in 20 mM Tris-HCl, pH 7.5,
50mMNaCl buffer. GST-tagged tail fragment of twinfilin-1was
eluted from beads with 20 mM glutathione without thrombin
cleavage. His-tagged EGFP-capping protein was immobilized
with nickel-nitrilotriacetic acid-agarose beads andwashedwith
20mMTris-HCl, pH 7.5, 250mMNaCl, 25mM imidazole buffer.
Protein was eluted with 20mMTris-HCl, pH 7.5, 250mMNaCl,
250 mM imidazole buffer and further purified with a Superdex-
200 gel filtration column (GEHealthcare) in 20mMHEPES, pH
7.4, 100 mM NaCl buffer.
Lipids andmembrane probes
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC;
Avanti catalog number 850457), 1-palmitoyl-2-oleoyl-sn-gly-
cero-3-phosphoethanolamine (POPE; Avanti catalog number
850757), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine
(POPS; Avanti catalog number 840034), 1,2-dioleoyl-
sn-glycero-3-phospho-(1-myo-inositol-3-phosphate) (PI(3)P;
Avanti catalog number 850150), L--phosphatidylinositol-
4-phosphate (PI(4)P; Avanti catalog number 840045),
1,2-dioleoyl-sn-glycero-3-phospho-(1-myo-inositol-3,4-bis-
phosphate) (PI(3,4)P2; Avanti catalog number 850153),
1,2-dioleoyl-sn-glycero-3-phospho-(1-myo-inositol-3,5-
bisphosphate) (PI(3,5)P2; Avanti catalog number 850154), L-
-phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2; Avanti
catalog number 840046), and 1,2-dioleoyl-sn-glycero-3-phos-
pho-(1-myo-inositol-3,4,5-trisphosphate) (PI(3,4,5)P3,
Avanti catalog number 850156) were purchased from Avanti
Polar Lipids. Rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-
Figure7.Aworkingmodel for the inhibitionof twinfilin-1byaphosphoi-
nositide-rich membrane. A, twinfilin-1 interacts, through its C-terminal
ADF-Hdomain,with anADP-actinmonomer andprevents its associationwith
filament ends. B, the C-terminal tail of twinfilin-1 can anchor the protein onto
a phosphoinositide-rich membrane through electrostatic interactions
between the positively charged residues of the protein and negatively
charged lipid headgroups. C, membrane-tethering (driven by the C-terminal
tail) places the actin-binding ADF-H domains of twinfilin in contact with the
membrane. Because the ADF-H domains associate with phosphoinositide
through an interface that overlaps with the actin-binding sites, this leads to
inhibition of the actin-binding activities of twinfilin-1.D, because the binding
sites for phosphoinositides and capping protein overlap in the tail of twinfi-
lin-1, phosphoinositide binding is also expected to inhibit the interaction of
twinfilin with capping protein.
Mechanism of twinfilin-PI(4,5)P2 interaction
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phosphoethanolamine (rhodamine-DHPE; Thermo Fisher cat-
alog number L1392) was purchased from Thermo Fisher. DPH
(catalog numberD208000Aldrich) was purchased fromMerck.
Lipid vesicle cosedimentation assay
Multilamellar vesicles were prepared as described earlier
(19). In most experiments (differences are specified in figure
legends), 2 and 500 M proteins and lipid vesicles, respectively,
were mixed in 20 mM HEPES, pH 7.4, 100 mM NaCl reaction
buffer and incubated for 30 min at room temperature. Lipid
composition in vesicles was commonly POPC:POPE:POPS:
PI(4,5)P2:rhodamine-POPE 50:18:20:10:2, thus mimicking the
inner leaflet of the plasma membrane. However, in lipid-spec-
ificity assays, we used a phosphoinositide concentration of 5%
to avoid saturated binding and hence to detect differences in
binding with various phosphoinositide species more clearly.
The reaction mixture was centrifuged at 100,000 rpm with a
Beckman TLA-100 rotor for 30 min at room temperature.
Equal amounts of supernatants and pellets were loaded for
SDS-PAGE and after electrophoresis were stained with Brilliant
Blue G (Sigma-Aldrich). Intensities of twinfilin-1 bands were
quantified with ImageJ. In each assay, the amount of nonspecific
aggregation of protein was taken into account through a control
sample consisting of only a protein and a reaction buffer. This
background was always subtracted from other samples.
Lipid coflotation assay
Interactions between proteins and multilamellar lipid
vesicles were examined with a lipid coflotation assay (55). The
lipid composition was POPC:POPS:POPE:PI(4,5)P2:rhoda-
mine-POPE 50:20:20:10:2. Protein and lipids with final concen-
trations of 1 M and 1 mM, respectively, were incubated for 30
min in 20mMHEPES, pH7.4, containing 0.3M sucrose and then
brought to 30% sucrose concentration. The reaction mixture
was overlaid with 25 and 0% sucrose in 20 mM HEPES, pH 7.4,
buffer and centrifuged at 240 000  g for 30 min at 4 °C. Four
fractions were collected as described elsewhere (56) and ana-
lyzed by SDS-PAGE. Protein amounts were quantified with
ImageJ, and liposome amounts were measured with an Agilent
Cary Eclipse fluorescence spectrometer at 550- and 580-nm
excitation and emission wavelengths, respectively.
DPH anisotropy assay
The fluorescence anisotropy of DPH was measured in a
3-mm-path-length quartz cuvette with PerkinElmer Life Sci-
ences LS-55 spectrometer. The final concentration of lipid ves-
icles was 40 M in 100 l of reaction buffer (20 mMHEPES, pH
7.4, 100 mMNaCl). Lipid composition was POPC:POPE:POPS:
PI(4,5)P2:DPH 50:20:20:10:1/500, and lipids were extruded
through 100-nm filters before measurements.
Actin filament cosedimentation assay
The final concentration of 3 M muscle actin was polymer-
ized for 30 min in a modified F-buffer (5 mM Tris-HCl, pH 8,
0.05 mM CaCl2, 0.5 mM 1,4-dithiothreitol (DTT), 0.2 mM ATP,
100 mM KCl, 1.25 mM MgCl2, 1 mM EGTA) with or without
0–10 M full-length or C-terminally deleted twinfilin and 1 mM
multilamellar vesicles. Spectrin-actin seeds were used to initialize
the polymerization as described earlier (57). Lipid composition of
vesicles was POPC:POPE:POPS:PI(4,5)P2 40:20:20:20. Actin fila-
mentsweresedimentedbycentrifugationat75,000rpmfor30min
with a TLA-100 rotor. Equal amounts of supernatant and pellet
fractions were analyzed by SDS-PAGE, and intensities of actin
bands were determined with ImageLab (Bio-Rad).
Microscale thermophoresis
MST measurements were performed in 20 mM sodium phos-
phate buffer, pH 7.4, 150 mM NaCl, 0.05% Tween 20, 0.1 mg/ml
BSA, 5 mM DTT with Monolith standard treated capillaries
(NanoTemper Technologies) and Monolith NT.115 (Nano-
Temper Technologies). The light-emitting diode (LED) power
and the MST power were 40 and 60%, respectively. The concen-
trationofEGFP-cappingproteinwas50nM, and theconcentration
of twinfilins ranged from 0.7629 nM to 25 M. Changes in ther-
mophoretic signals were analyzed with MO.Affinity Analysis
software (NanoTemper Technologies). Data were fitted with
Prism (GraphPad Software) as described earlier (47) with the
following equation,
BL	/B0	 1/
1 KD/L	
h (Eq. 1)
where [BL] is the concentration of formed complexes, [B0] is
the total concentration of binding sites, KD is the dissociation
constant, [L] is the concentration of twinfilin, and h represents
the Hill coefficient.
MD simulations and analysis
The atomistic CHARMM36 force field was used for proteins
and lipids as described earlier (58, 59), and the TIP3P-
CHARMM model was used for water (60). The protein struc-
ture for twinfilin was taken from the Protein Data Bank (code
2HD7) (35). Twinfilin was explored in 11 different systemswith
or without amembrane (see Table S1). For simulations inwater
solution without a membrane (systems 1–4), the C-terminal
tail was placed in a box of 11  11  11 nm3 to ensure no
interaction with its image even in the coil-starting simulations
and to confirm that the peptide was always very well-solvated.
For the bilayer simulations (systems 5–10), lipid bilayers of a
size of about 11 11 nm2 were used (61). The upper leaflet had
a lipid composition of POPC:POPE:POPS:PI(4,5)P2 50:20:20:
10, matching the lipid content of membranes considered in
the experiments. The lower leaflet had a lipid composition of
POPC:POPE:POPS 60:20:20 to confine PI(4,5)P2 and its speci-
ficity to the upper leaflet. The concentration of NaCl was 100
mM in every simulation system. To build systems 5 and 7 (Table
S1), i.e. the C-terminal domain attached to the 34-residue tail in
either a -sheet or an -helical structure, we performed clus-
tering analysis as explained in the supporting information. In
every system studied, the protein was placed at a distance of
more than 3nm from theupper leaflet and the periodic image of
the lower image. This yielded a very large simulation box, which
subsequently guaranteed well-solvated lipids with more than
120 water molecules per lipid in all cases.
All simulations were performed in the NPT ensemble using
GROMACS 5.0.4 (62). The temperature in all the systems was
maintained at 303 K using the Nose´–Hoover coupling method
Mechanism of twinfilin-PI(4,5)P2 interaction
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(63, 64) with a time constant of 1 ps. The temperature of the
protein, lipids, and solvent molecules was controlled indepen-
dently. The pressure coupling was done with the Parrinello–
Rahman semi-isotropic barostat (65)with a coupling constant of 1
ps and a referencepressure of 1 bar.The equations ofmotionwere
integratedwith a time step of 2 fs. The LINCS algorithm (66) con-
strained all bonds involving hydrogens. A cutoff radius of 1.2 nm
was used to switch off van derWaals interactions, and the smooth
particle mesh Ewald technique (67) was used to calculate long-
range Coulomb interactions. Electrostatic representations in
Fig. S2 were drawn with the Adaptive Poisson-Boltzmann Solver
(APBS) electrostatics (68). Each system was simulated over times
(seeTable S1) thatwere sufficiently long for observing and analyz-
ing protein conformational behavior and/or the binding process.
To improve sampling, the simulations for the key systems were
repeated several times (Table S1).
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